• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
FDA Watch: How Could the Change in US Government Affect IVDs and Labs?

FDA Watch: How Could the Change in US Government Affect IVDs and Labs?

by Rachel Muenz | Jan 6, 2025 | Essential, FDA-lir, Lab Industry Advisor

Experts say new leadership could impact the cost and availability of IVDs as well as patients’ ability to afford lab testing

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
New and Improved: The Latest Research in Disease Screening

New and Improved: The Latest Research in Disease Screening

by Michael Schubert, PhD | Dec 17, 2024 | Clinical Diagnostics Insider, Emerging Tests-dtet, Top of the News-dtet

New ideas and innovations look beyond conventional screening options to facilitate improved disease diagnosis and patient outcomes

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Lab Institute Virtual Event: Advancing the Profession of Diagnostic Medicine

Lab Institute Virtual Event: Advancing the Profession of Diagnostic Medicine

by G2 Intelligence Staff | Sep 16, 2024 | OLP-Regular, Webinars

Our event equips diagnostic medicine professionals with innovative strategies to advance their practice, enhance patient care, and drive the future of the field

Special Analysis: Addressing Key Concerns Around the FDA’s Final LDTs Rule

Special Analysis: Addressing Key Concerns Around the FDA’s Final LDTs Rule

by Scott Wallask | Jul 4, 2024 | Elite, FDA-lca, Lab Industry Advisor

Experts answer key questions related to laboratory-developed test regulation during G2 Intelligence webinar.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Diagnostics Pipeline: Startup Women’s Health Lab Receives $4M in Federal Grants

Diagnostics Pipeline: Startup Women’s Health Lab Receives $4M in Federal Grants

by Ron Shinkman | Jun 27, 2024 | Clinical Diagnostics Insider, FDA-dtet

The grants, which include $3 million from the NIH and $1 million from the NSF, will help the company develop point-of-care tests

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com